Studi Clinici Milteforan

2020/09/15

Bibliografia:

Interferon-gamma (INF-c), IL4 expression levels and Leishmania DNA load as prognostic markers for monitoring response to treatment of leishmaniotic dogs with miltefosine and allopurinol. Laura Manna, Stefano Reale, Esther Picillo, Fabrizio Vitale, Angelo Elio Gravino. Cytokine 44 (2008) 288–292
https://www.sciencedirect.com/science/article/abs/pii/S1043466608007369

Study of efficacy of miltefosine and allopurinol in dogs with leishmaniosis. Laura Manna, Fabrizio Vitale, Stefano Reale, Esther Picillo, Gianluca Neglia, Francesco Vescio, Angelo Elio Gravino. The Veterinary Journal 182 (2009) 441–445 https://www.sciencedirect.com/science/article/abs/pii/S1090023308002992

Administration of Miltefosine and Meglumine Antimoniate in Healthy Dogs: Clinicopathological Evaluation of the Impact on the Kidneys. PAOLO BIANCIARDI, CLAUDIO BROVIDA, MARIALUISA VALENTE, LUCA ARESU, LAURA CAVICCHIOLI, CLAUDIA VISCHER, LUCIE GIROUD, AND MASSIMO CASTAGNARO Toxicologic Pathology, 37: 770-775, 2009 http://tpx.sagepub.com/content/37/6/770

Resolution of tongue lesions caused by Leishmania infantum in a dog treated with the association miltefosine-allopurinol. Valentina Foglia Manzillo, Rosa Paparcone, Silvia Cappiello, Roberta De Santo, Paolo Bianciardi, Gaetano Oliva. Parasites & Vectors 2009, 2(Suppl 1):S6 http://www.parasitesandvectors.com/content/2/S1/S6

Comparative study on the short term efficacy and adverse effects of miltefosine and meglumine antimoniate in dogs with natural leishmaniosis Marta Mateo & Laurence Maynard & Claudia Vischer & Paolo Bianciardi & Guadalupe Miró. Parasitol Res (2009) 105:155–162 https://link.springer.com/article/10.1007/s00436-009-1375-3

Multicentric, controlled clinical study to evaluate effectiveness and safety of miltefosine and allopurinol for canine leishmaniosis. Guadalupe Mirò, Gaetano Oliva, Israel Cruz, Carmen Cañavate, Michele Mortarino, Claudia Vischer and Paolo Bianciardi. 2009 ESVD and ACVD, Veterinary Dermatology, 20, 397–404. https://onlinelibrary.wiley.com/doi/10.1111/j.1365-3164.2009.00824.x

Clinical efficacy and tolerance of miltefosine in the treatment of canine leishmaniosis. Virginie Woerly & Laurence Maynard & Annaële Sanquer & Hyone-Myong Eun. Parasitol Res (2009) 105:463–469 https://link.springer.com/article/10.1007/s00436-009-1404-2

Long-term follow-up of dogs with leishmaniosis treated with meglumine antimoniate plus allopurinol versus miltefosine plus allopurinol. Laura Manna, Raffaele Corso, Giorgio Galiero, Anna Cerrone, Paolo Muzj and Angelo Elio Gravino. Parasites & Vectors (2015) 8:289 https://parasitesandvectors.biomedcentral.com/articles/10.1186/s13071-015-0896-0

SEMINAL PARAMETERS IN DOGS TREATED FOR CANINE LEISHMANIASIS: A COMPARATIVE RANDOMIZED FIELD STUDY BETWEEN MILTEFOSINE AND MEGLUMINE ANTIMONIATE PROTOCOLS Albrizio M. ,Paradies P., Sasanelli M, Iarussi F, Capogna A., Paradies R., Oliva G., DeMari K., McGahie D., Aiudi G. Poster at 6th World Congress on Leishmaniasis May 2017. http://worldleish2017.org/documentos/Abstracts_BookWL6_final.pdf

C-1444: CLINICAL EFFICACY AND TOLERANCE OF MILTEFORAN^® IN THE TREATMENT OF CANINE VISCERAL LEISHMANIASIS IN NATURALLY INFECTED DOGS WITH L. INFANTUM (SYN CHAGASI). De Mari K., Avino V. C., Nogueira F. S., Menz I., Moreira M. A. B. M., Chioccola V. L. P., Romariz A. P. P. L., Molla L. M. Poster at 6th World Congress on Leishmaniasis May 2017. http://worldleish2017.org/documentos/Abstracts_BookWL6_final.pdf

C-1446: EVALUATION OF THE POTENTIAL OF INFECTIVITY OF DOGS WITH VISCERAL LEISHMANIASIS AND TREATED WITH MILTEFOSINE BY USING A XENODIAGNOSIS. De Mari K., Avino V. C., Nogueira F. S., Menz I., Moreira M. A. B. M., Chioccola V. L. P., Fredy Galvis Ovallos F. G., Romariz A. P. P. L., Molla L. M., Dal’Bó C. M. R. Poster at 6th World Congress on Leishmaniasis May 2017. http://worldleish2017.org/documentos/Abstracts_BookWL6_final.pdf

C0713 TOLERANCE AND CLINICAL EFFICACY OF TWO DOSING MILTEFOSINE REGIMENS ASSOCIATED WITH ALLOPURINOL, IN THE TREATMENT OF CANINE LEISHMANIASIS: A RANDOMIZED FIELD STUDY. Paola Paradies, Fabrizio Iarussi, Giulio Aiudi, Maria Albrizio, Antonio Capogna, Romina Paradies, Valentina Foglia Manzillo, Gaetano Oliva, Karine De Mari, David McGahie, Mariateresa Sasanelli. Poster at 6th World Congress on Leishmaniasis May 2017. http://worldleish2017.org/documentos/Abstracts_BookWL6_final.pdf

Use of miltefosine to treat canine visceral leishmaniasis caused by Leishmania infantum in Brazil. Fabio dos Santos Nogueira, Valdir Carlos Avino, Fredy Galvis-Ovallos, Vera Lucia Pereira-Chioccola, Marcio Antonio Batistella Moreira, Ana Paula Peres Lopes Romariz, Leticia M. Molla and Ingrid Menz. Parasites & Vectors (2019) 12:79 https://parasitesandvectors.biomedcentral.com/articles/10.1186/s13071-019-3323-0

Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis Thomas P. C. Dorlo,Manica Balasegaram, Jos H. Beijnen and Peter J. de Vries. J Antimicrob Chemother 67(11) 2012. https://www.researchgate.net/publication/230009435_Miltefosine_A_review_of_its_pharmacology_and_therapeutic_efficacy_in_the_treatment_of_leishmaniasis

Comparative study of the use of miltefosine, miltefosine plus allopurinol, and allopurinol in dogs with visceral leishmaniasisExperimental Parasitology, Volume 217, July 2020, Article Number 107947Álvaro Felipe de Lima Ruy Dias, Eveline da Cruz Boa Sorte Ayres, Domingos Tabajara de Oliveira Martins, Fernanda Harumi Maruyama, Ruberlei Godinho de Oliveira, Matheus Roberto de Carvalho, Arleana do Bom Parto Ferreira de Almeida, Anna Louisa de Souza Teixeira, Adriane Jorge Mendonça, Valéria Régia Franco Sousa https://doi.org/10.1016/j.exppara.2020.107947

Tags :